Eagle Pharmaceuticals, Inc. Patent Applications Pending
15 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-09-04: Application 19318808; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Docketed New Case - Ready for Examination.
- 2025-06-11: Application 19235248; Invention FULVESTRANT FORMULATIONS; Applicant Eagle Pharmaceuticals, Inc.; Status Docketed New Case - Ready for Examination.
- 2025-06-05: Application 19229424; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Docketed New Case - Ready for Examination.
- 2024-10-09: Application 18910904; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Docketed New Case - Ready for Examination.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2025-09-04 | 19318808 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Docketed New Case - Ready for Examination | US20260000767A1 | Srikanth Sundaram | United States | CENTRAL, DOCKET |
| 2025-06-11 | 19235248 | FULVESTRANT FORMULATIONS | Eagle Pharmaceuticals, Inc. | Docketed New Case - Ready for Examination | US20250302966A1 | Bulusu Bhanu TEJA Nagesh R. PALEPU | India United States | CENTRAL, DOCKET |
| 2025-06-05 | 19229424 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Docketed New Case - Ready for Examination | US20250295637A1 | Nagesh R. PALEPU Philip Christopher BUXTON | United States United Kingdom | CENTRAL, DOCKET |
| 2024-10-09 | 18910904 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Docketed New Case - Ready for Examination | US20250177356A1 | Nagesh R. Palepu Philip Christopher Buxton | United States United Kingdom | ARNOLD, ERNST V |
| 2024-08-09 | PCTUS2024041709 | USE OF REMIMAZOLAM FOR PEDIATRIC SEDATION | EAGLE PHARMACEUTICALS, INC. PAION UK LIMITED | PCT - International Search Report Mailed to IB | LYNN BICHAJIAN KEIRA MASON THOMAS STOHR PIETER COLIN MICHAEL M.R.F. STRUYS | United States United States Germany Netherlands Netherlands | KIM, HARRY CHONG HYUN | |
| 2023-09-20 | 18470621 | PEMETREXED FORMULATIONS | Eagle Pharmaceuticals, Inc. | Non Final Action Mailed | US20240009198A1 | Feng-Jing CHEN Steven L. KRILL | United States United States | VANHORN, ABIGAIL LOUISE |
| 2023-08-28 | 18456772 | PEMETREXED FORMULATIONS | Eagle Pharmaceuticals, Inc. | Non Final Action Mailed | US20230414623A1 | Feng-Jing CHEN Steven L. KRILL | United States United States | VANHORN, ABIGAIL LOUISE |
| 2023-08-11 | 63519082 | USE OF REMIMAZOLAM FOR PAEDIATRIC SEDATION | Eagle Pharmaceuticals, Inc. | Provisional Application Expired | Lynn Bichajian | United States | ||
| 2022-10-06 | 17995608 | METHODS OF TREATING VIRAL INFECTIONS | EAGLE PHARMACEUTICALS, INC. | Notice of Allowance Mailed -- Application Received in Office of Publications | US20230149364A1 | Adrian HEPNER | United States | FETTEROLF, BRANDON J |
| 2021-04-08 | PCTUS2021026305 | METHODS OF TREATING VIRAL INFECTIONS | EAGLE PHARMACEUTICALS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ADRIAN HEPNER | United States | ||
| 2021-04-08 | PCTUS2021026304 | METHODS OF TREATING CORONAVIRUS INFECTIONS | EAGLE PHARMACEUTICALS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ADRIAN HEPNER | United States | ||
| 2021-04-08 | PCTUS2021026303 | METHODS OF TREATING SEVERE ACUTE RESPIRATORY SYNDROME | EAGLE PHARMACEUTICALS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ADRIAN HEPNER | United States | ||
| 2021-04-08 | PCTUS2021026302 | METHODS OF TREATING SARS-COV-2 INFECTIONS | EAGLE PHARMACEUTICALS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ADRIAN HEPNER | United States | ||
| 2018-05-21 | 62674422 | Dantrolene Prodrugs and Methods Of Their Use | Eagle Pharmaceuticals, Inc. | Provisional Application Expired | Charles Wescott Adrian Hepner | United States United States | ||
| 2017-10-20 | 62575124 | DANTROLENE PRODRUGS AND METHODS OF THEIR USE | Eagle Pharmaceuticals, Inc. | Provisional Application Expired | Charles Wescott | United States |